Short Interest in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Drops By 82.9%

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) saw a significant decline in short interest during the month of July. As of July 15th, there was short interest totalling 37,700 shares, a decline of 82.9% from the June 30th total of 220,500 shares. Based on an average trading volume of 352,900 shares, the short-interest ratio is presently 0.1 days. Approximately 7.8% of the shares of the stock are short sold.

Institutional Investors Weigh In On Bluejay Diagnostics

An institutional investor recently bought a new position in Bluejay Diagnostics stock. Armistice Capital LLC bought a new stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 24,230 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned 1.95% of Bluejay Diagnostics as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 18.47% of the company’s stock.

Bluejay Diagnostics Stock Down 9.3 %

BJDX traded down $0.06 during trading on Friday, hitting $0.58. The company’s stock had a trading volume of 391,460 shares, compared to its average volume of 646,816. Bluejay Diagnostics has a 12 month low of $0.51 and a 12 month high of $89.12. The stock has a market capitalization of $325,640.00, a price-to-earnings ratio of -0.01 and a beta of 0.82. The firm’s 50 day moving average price is $2.38 and its two-hundred day moving average price is $4.72.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.